Cargando…
Development and validation of a five-immune gene prognostic risk model in colon cancer
BACKGROUND: Colon cancer is a common and highly malignant cancer. Its morbidity is rapidly increasing, and its prognosis is poor. Currently, immunotherapy is a rapidly developing therapeutic modality of colon cancer. This study aimed to construct a prognostic risk model based on immune genes for the...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204296/ https://www.ncbi.nlm.nih.gov/pubmed/32375704 http://dx.doi.org/10.1186/s12885-020-06799-0 |